The gut microbiome plays a crucial role in diabetes, influencing glucose metabolism, insulin sensitivity, and inflammation. Dysbiosis, or an imbalance in gut microbes, has been linked to the development of type 2 diabetes and obesity. Research suggests that modulating the gut microbiota through diet, probiotics, or prebiotics could improve metabolic health and offer new therapeutic avenues for diabetes management.
5.1 Gut bacteria influencing insulin resistance
5.2 Microbiome-targeted therapies for Type 2 diabetes
5.3 Role of short-chain fatty acids in glycemic control
5.4 Microbiota interventions in prediabetes
5.5 Antibiotics and their impact on gut health in diabetes
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
